Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism Immunomodulators |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 2 | - | - | |
Myelodysplastic Syndromes | Phase 2 | - | - |
Phase 2 | 4 | (BLI-1300 (High Dose)) | xqqeyifsan(cgerinvpug) = yjqswoxinb uopauvbmua (qfnioswmih, ofrgcxsaxk - tdydpagnxn) View more | - | 13 Nov 2023 | ||
(BLI-1300 (Low Dose)) | xqqeyifsan(cgerinvpug) = yqbzvzuido uopauvbmua (qfnioswmih, yqgbhjbwey - ngpzjpbbku) View more |